CN1303696A - 芦荟蚂蚁超细粉 - Google Patents
芦荟蚂蚁超细粉 Download PDFInfo
- Publication number
- CN1303696A CN1303696A CN 99114593 CN99114593A CN1303696A CN 1303696 A CN1303696 A CN 1303696A CN 99114593 CN99114593 CN 99114593 CN 99114593 A CN99114593 A CN 99114593A CN 1303696 A CN1303696 A CN 1303696A
- Authority
- CN
- China
- Prior art keywords
- aloe
- ultra
- powder
- fine
- ant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241001116389 Aloe Species 0.000 title claims abstract description 40
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 40
- 239000000843 powder Substances 0.000 title claims abstract description 40
- 241001251068 Formica fusca Species 0.000 claims description 22
- 230000000694 effects Effects 0.000 description 5
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 239000000463 material Substances 0.000 description 3
- 235000018102 proteins Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- -1 triterpenoid compound Chemical class 0.000 description 3
- 241001620634 Roger Species 0.000 description 2
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036737 immune function Effects 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- 239000011701 zinc Substances 0.000 description 2
- 229910052725 zinc Inorganic materials 0.000 description 2
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- ZKHQWZAMYRWXGA-KQYNXXCUSA-J ATP(4-) Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)[C@H]1O ZKHQWZAMYRWXGA-KQYNXXCUSA-J 0.000 description 1
- ZKHQWZAMYRWXGA-UHFFFAOYSA-N Adenosine triphosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)C(O)C1O ZKHQWZAMYRWXGA-UHFFFAOYSA-N 0.000 description 1
- 235000002961 Aloe barbadensis Nutrition 0.000 description 1
- 244000242092 Aloe saponaria Species 0.000 description 1
- 244000186892 Aloe vera Species 0.000 description 1
- HKIKAXXIWJHWLY-ZIIYPAMZSA-N Aloesin Chemical compound C=12OC(CC(=O)C)=CC(=O)C2=C(C)C=C(O)C=1[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HKIKAXXIWJHWLY-ZIIYPAMZSA-N 0.000 description 1
- HKIKAXXIWJHWLY-QEVGBQTESA-N Aloesin Natural products O=C(CC=1Oc2c([C@H]3[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O3)c(O)cc(C)c2C(=O)C=1)C HKIKAXXIWJHWLY-QEVGBQTESA-N 0.000 description 1
- AFHJQYHRLPMKHU-XXWVOBANSA-N Aloin Natural products O=C1c2c(O)cc(CO)cc2[C@H]([C@H]2[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O2)c2c1c(O)ccc2 AFHJQYHRLPMKHU-XXWVOBANSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 208000009084 Cold Injury Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 108060003951 Immunoglobulin Proteins 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 208000007107 Stomach Ulcer Diseases 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 238000004026 adhesive bonding Methods 0.000 description 1
- 210000004404 adrenal cortex Anatomy 0.000 description 1
- 150000001335 aliphatic alkanes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- KFJNVVJUICKJEQ-LQDZTQBFSA-N aloenin Chemical compound O1C(=O)C=C(OC)C=C1C1=C(C)C=C(O)C=C1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 KFJNVVJUICKJEQ-LQDZTQBFSA-N 0.000 description 1
- AFHJQYHRLPMKHU-OSYMLPPYSA-N aloin A Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1[C@@H]1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-OSYMLPPYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 230000002595 cold damage Effects 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 201000005917 gastric ulcer Diseases 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 150000004338 hydroxy anthraquinones Chemical class 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 102000018358 immunoglobulin Human genes 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- AFHJQYHRLPMKHU-UHFFFAOYSA-N isobarbaloin Natural products OC1C(O)C(O)C(CO)OC1C1C2=CC(CO)=CC(O)=C2C(=O)C2=C(O)C=CC=C21 AFHJQYHRLPMKHU-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 230000000527 lymphocytic effect Effects 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000011572 manganese Substances 0.000 description 1
- 229910052748 manganese Inorganic materials 0.000 description 1
- 238000004137 mechanical activation Methods 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 235000010755 mineral Nutrition 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 244000302373 pita floja Species 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004223 radioprotective effect Effects 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 208000003265 stomatitis Diseases 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 201000004647 tinea pedis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种芦荟蚂蚁超细粉,由粒度在200目以上的超细芦荟粉和超细蚂蚁粉混合而成,超细芦荟粉和超细蚂蚁粉的重量配比为:超细芦荟粉∶超细蚂蚁粉=2~4∶8~6。本发明同时保持芦荟和蚂蚁的天然有效成分,使两者优势互补,且颗粒小,易被人体吸收。
Description
本发明涉及一种保健食品。
国内外专家研究分析结果表明：芦荟中含有有机活性成份羟基蒽醌类衍生物，包括芦荟大黄素苷、芦荟大黄素、芦荟宁、芦荟苦素等20多种，其中芦荟大黄素是最基本成份之一，这些物质大多数具有杀菌、抑菌、分解毒素、消除炎症和促进伤口愈合的作用。芦荟中富含的胶粘质中含有6碳糖等，芦荟中的多糖体是由糖分和蛋白质结合而成的复合蛋白质，平均分子量为5000～45万，具有改善虚弱体质、强化免疫机能、抗癌等效果。芦荟中还含有19种氨基酸，其中8种是人体必需氨基酸而又不能自身合成的，由于芦荟氨基酸组成比较平衡，所以称芦荟是21世纪最有希望的保健品。芦荟还含有脂类及有机酸：类异戊二烯、烷烃、脂肪酸、酯类及甾醇类物质、琥珀酸、苹果酸、乳酸等，芦荟还含有多种矿物质、维生素及酶，现有的医学研究证明芦荟具有治便秘、高血压、胃炎、胃溃疡、口腔炎、糖尿病、促进伤口愈合、烫伤、冻伤、脚癣、湿疹、促免疫、抗肿瘤、抗辐射等作用。蚂蚁体内含有20多种氨基酸，其中人体所必需的八种氨基酸齐全，蛋白质含量丰富，不同的蚁种有所差别，一般在42～67％之间；含有多种维生素，如VB1、VB2、VB12、VE等；含28种微量元素，尤以锌、锰的含量为最丰富，其中锌的含量比动物性食品多10几倍，还含有三萜类化合物、三磷酸腺苷、甾体类化合物，如性激素、类肾上腺皮质样物质、多种生物碱及醛类化合物等。我国医学专家的药理研究证实，食用蚂蚁(例拟黑多刺蚁)具有镇静、抗炎、护肝、平喘、解痉等方面的作用，它能够促进免疫球蛋白的形成，促进淋巴细胞的转化，提高人体免疫功能的作用，临床上已用来治疗类风湿关节炎、神经衰弱、慢性肝炎等疾病。
目前市场上仅有单一的芦荟粉和单一的蚂蚁粉出售，或以蚂蚁为主，佐以其它中草药制成中成药。
本发明的目的在于提供一种同时具有芦荟和蚂蚁的有效成份，组方简单、颗粒细，易被人体吸收的芦荟蚂蚁超细粉。
本发明的技术解决方案是：
一种芦荟蚂蚁超细粉，其与现有技术的不同之处是：由粒度在200目以上(粒径小于74μm)的超细芦荟粉和超细蚂蚁粉混合而成，超细芦荟粉和超细蚂蚁粉的重量配比为：超细芦荟粉∶超细蚂蚁粉=2～4∶8～6。
超细芦荟粉和超细蚂蚁粉的重量配比为：超细芦荟粉∶超细蚂蚁粉=3～4∶7～6。超细芦荟粉和超细蚂蚁粉的粒度为500目～12500目(粒径为74μm～1μm)。
本发明同时保持芦荟和蚂蚁的有效成份，使两者优势互补，且颗粒小，易被人体吸收。
下面结合实施例对本发明作进一步说明。
实施例1：
将芦荟(例：大芦荟、皂质芦荟、库拉索芦荟、绿芦荟、华芦荟等)和蚂蚁(例拟黑多刺蚁)用常规方法进行机械粉碎成片或粉末，再采用现有的超细技术进行处理，得到粒度为500目以上(例200目、500目、800目、1200目、2500目、6250目、12500目)的芦荟和蚂蚁超细粉末，然后按芦荟∶蚂蚁=3∶7的重量比混合均匀，即得成品，并可进一步装入胶囊或压成片剂。
实施例2：
芦荟和蚂蚁超细粉末混合时的重量比为芦荟∶蚂蚁=4∶6，其余均同实施例1。
实施例3：
芦荟和蚂蚁超细粉末混合时的重量比为芦荟∶蚂蚁=2∶8，其余均同实施例1。
Claims (3)
1、一种芦荟蚂蚁超细粉，其特征在于：由粒度在200目以上的超细芦荟粉和超细蚂蚁粉混合而成，超细芦荟粉和超细蚂蚁粉的重量配比为：超细芦荟粉∶超细蚂蚁粉=2～4∶8～6。
2、根据权利要求1所述的芦荟蚂蚁超细粉，其特征在于：超细芦荟粉和超细蚂蚁粉的重量配比为：超细芦荟粉∶超细蚂蚁粉=3～4∶7～6。
3、根据权利要求1所述的芦荟蚂蚁超细粉，其特征在于：超细芦荟粉和超细蚂蚁粉的粒度为200目～12500目。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99114593 CN1303696A (zh) | 1999-12-02 | 1999-12-02 | 芦荟蚂蚁超细粉 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 99114593 CN1303696A (zh) | 1999-12-02 | 1999-12-02 | 芦荟蚂蚁超细粉 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1303696A true CN1303696A (zh) | 2001-07-18 |
Family
ID=5277654
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 99114593 Pending CN1303696A (zh) | 1999-12-02 | 1999-12-02 | 芦荟蚂蚁超细粉 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1303696A (zh) |
-
1999
- 1999-12-02 CN CN 99114593 patent/CN1303696A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69734841T2 (de) | Zusammensetzungen auf pflanzlicher Kohlenhydratbasis als Nahrungsergänzungsstoffe | |
| CN104304749B (zh) | 一种提高奶牛产奶量、改善乳品品质的中草药饲料添加剂 | |
| Kumar et al. | Ficus religiosa: A wholesome medicinal tree | |
| CN103120107A (zh) | 营养强化富硒大米及其栽培方法 | |
| CN102687822A (zh) | 一种枸杞咀嚼片及其制备方法 | |
| CN103505717A (zh) | 一种含有香菇菌丝体多糖的组合物及其应用 | |
| CN102246955A (zh) | 一种降压降脂的有机营养粉及其制备方法 | |
| CN108084235A (zh) | 一种柳树皮提取物及其制备方法 | |
| CN1121148C (zh) | 红珍珠果酱 | |
| CN1303696A (zh) | 芦荟蚂蚁超细粉 | |
| CN103156983A (zh) | 一种预防肉鸡呼吸道疾病的饲料中药添加剂及其生产方法 | |
| CN101238851A (zh) | 一种促肉鸡育肥增重的中药组合物及其制备方法 | |
| CN105410279A (zh) | 一种罗汉果板蓝根提取物复合茶及其制备方法 | |
| CN103571711A (zh) | 一种玛咖青稞酒的制作方法 | |
| CN1069817C (zh) | 沙棘茶及其制备方法 | |
| CN1303711A (zh) | 芦荟灵芝超细粉 | |
| CN100341826C (zh) | 豆科牧草专用微肥 | |
| CN113548920A (zh) | 一种尤加利专用肥及其制作方法 | |
| CN1301507A (zh) | 鹿茸保健茶及其生产方法 | |
| CN1220095A (zh) | 一种鱼腥草袋泡茶及其配制方法 | |
| CN102488280A (zh) | 一种银杏叶双孢菇复合保健饮料及其制作方法 | |
| CN1413704A (zh) | 化风丹 | |
| CN102626168A (zh) | 一种银杏叶提取工艺及银杏苦丁茶的加工方法 | |
| CN1089559C (zh) | 天然矿物富硒饲料及生产方法 | |
| CN105981940A (zh) | 蛋鸭富硒饲料及富硒鸭蛋的生产方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |